Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Memorial Sloan–Kettering Cancer Center Stories

2012-09-19 02:26:56

NEW YORK, Sept. 19, 2012 /PRNewswire/ -- Online registration is now open for Cycle for Survival, Memorial Sloan-Kettering Cancer Center's national indoor team cycling event that has raised more than $17 million for rare cancer research, funding more than 50 clinical trials and research studies since 2007. Cycle 2013 is expected to be the largest event yet, spanning 10 locations in eight states and bringing together more than 13,000 cyclers nationwide. The 2013 event schedule is as follows:...

2012-07-19 02:25:34

NEWARK, N.J., July 19, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A(TM) in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City. Patients...

2012-05-17 12:41:57

Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas – the most common type of non-small cell lung cancer – and have developed drugs that can successfully address them, scientists have not yet identified targeted therapies for another type of non-small cell lung...

2012-04-24 02:30:53

PURCHASE, N.Y., April 24, 2012 /PRNewswire/ -- Everyone's a winner when they join the fight with The Stop & Shop Supermarket Company LLC throughout Connecticut, New York and New Jersey for a special fundraising day on Saturday, April 28, 2012 to benefit children's cancer research. Several brands of single-serve ice cream cups, shakes and smoothies, including those by Haagen-Dazs® brand, EDY'S® SLOW CHURNED® low fat ice cream, and SKINNY COW® low fat ice cream are...

2012-04-13 10:21:21

PURCHASE, N.Y., April 13, 2012 /PRNewswire/ -- Beginning today through July 12, 2012 The Stop & Shop Supermarket Company LLC customers will have the opportunity to help support pediatric cancer research at Memorial Sloan-Kettering Cancer Center (MSKCC) through Stop & Shop's annual Triple Winner Game®. Customers who make a $1 contribution* to MSKCC receive a Triple Winner scratch ticket and can win free store products, gift cards or cash prizes up to $10,000. (Logo:...

2012-04-04 02:30:02

DALLAS and NEW YORK, April 4, 2012 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that Memorial Sloan-Kettering Cancer Center (MSKCC) has added MuGard to its cancer supportive care pharmacy formulary. Patients undergoing cancer treatment will now have direct access to MuGard from the first day of...

2012-03-22 06:25:32

NEW YORK, March 22, 2012 /PRNewswire/ -- Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM (NYSE: IBM) have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices. The resulting decision support tool will help doctors everywhere create individualized cancer diagnostic and treatment recommendations for their patients based on current...

2012-03-13 15:00:00

MEMPHIS, Tenn., March 13, 2012 /PRNewswire/ -- Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis. To view the multimedia assets associated with this release, please click:...

2012-03-08 13:43:48

Study describes a rare case of the abscopal effect in a melanoma patient Research published today in the New England Journal of Medicine by scientists at the Ludwig Institute for Cancer Research (LICR) and Memorial Sloan-Kettering Cancer Center (MSKCC) showed that combining targeted radiation therapy with immunotherapy (ipilimumab), fostered a strong immune response and a favorable clinical outcome in a patient with melanoma, the most dangerous form of skin cancer. The size of both the...

2012-02-21 08:05:00

PALO ALTO, Calif., Feb. 21, 2012 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today announced that the Phase 2 investigator-led Telcyta trial in hematologic malignancies has been expanded to an additional investigational site, Memorial Sloan-Kettering Cancer Center (MSKCC). Based upon the results observed in Stage 1 of the trial, which is being conducted at the Robert Wood Johnson University Hospital under the direction of Joseph R. Bertino, MD of The Cancer Institute of New Jersey, an...